About CueZen
CueZen is a company based in Seattle (United States) founded in 2021 by Aloysius Lim, Ankur Teredesai, and Sunil Shinde. CueZen has raised $5.2 million across 1 funding round from investors including Point72 Ventures, Pack Ventures and Fortson Venture Capital. CueZen offers products and services including Personalization Engine and Health Coaching Platform. CueZen operates in a competitive market with competitors including Omega Therapeutics, BiomeSense, BAMF Health, InpharmD and Shengshi Technology, among others.
- Headquarter Seattle, United States
- Founders Aloysius Lim, Ankur Teredesai, Sunil Shinde
- SectorsHealthcareTechnology
- Email••••••••
- Website cuezen.com
- Social LinkedIn
- Legal Name Cuezen Labs Private Limited
- Date of Incorporation 07 Oct, 2024
- Jurisdiction Bangalore, Karnataka, India
- Annual Revenue₹2.02 Cr
FY 2025
- Net Profit₹19.7 Lakh
FY 2025 · 10% margin
- EBITDA₹29.7 Lakh
FY 2025 · 15% margin
- Total Equity Funding$5.2M (USD)
in 1 rounds
- Latest Funding Round$5.2M (USD), Seed
Apr 2025
- InvestorsPoint72 Ventures
& 2 more
Associated legal entities of CueZen
CueZen operates through Cuezen Labs Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Cuezen Labs Private Limited CIN U58200KA2024PTC193755 | Active | 07 Oct 2024 | Bangalore, Karnataka | ₹2.0 Cr | – | 2 | View details |
Products & Services of CueZen
CueZen offers a comprehensive portfolio of products and services, including Personalization Engine and Health Coaching Platform.
Engine for delivering hyper-personalized health coaching and nudges
Platform integrating AI for wellness and chronic care management
Funding Insights of CueZen
CueZen has successfully raised a total of $5.2M through 1 strategic funding round. The most recent funding activity was a Seed round of $5.2 million completed in April 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $5.2M
- Total Rounds 1
- Last Round Seed — $5.2M
- First Round $5.2M
(Apr 2025)
- Investors Count 3
All 1 funding rounds of CueZen with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Apr 2025 | $5.2M | Seed | – | Point72 Ventures |
3 investors in total: 3 institutional.
Investors in CueZen
CueZen has secured backing from 3 investors, including venture fund investors. Prominent investors backing the company include Point72 Ventures, Pack Ventures and Fortson Venture Capital.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Venture capital fund focused on seed to growth stage fintech, deep tech, and enterprise tech companies | – | p72.vc | New York, United States | |
Pack Ventures is involved in unspecified business activities. | – | packvc.com | - | |
Seed stage investments are offered by Fortson Venture Capital. | – | fortsonvc.com | United States |
Investor details for CueZen
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Board of directors of Cuezen Labs Private Limited (CueZen)
Cuezen Labs Private Limited is the primary company behind CueZen. The board of Cuezen Labs Private Limited currently have 2 directors; the longest-serving is Ranjith Parakkunnath, appointed in 2024.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Ranjith Parakkunnath DIN 06896577 | Director | 07 Oct 2024 | 2 yrs | Cuezen Labs Private Limited |
| Sharath Chandra Mysore Ganesh DIN 06896588 | Director | 07 Oct 2024 | 2 yrs | Cuezen Labs Private Limited |
People of CueZen
3 people are tracked at CueZen (3 in leadership).
| Name | Role | Group |
|---|---|---|
Aloysius Lim | Co-Founder | Leadership |
Ankur Teredesai | Co-Founder & CEO | Leadership |
Sunil Shinde | Co-Founder | Leadership |
Complete people profiles for CueZen
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Financials of CueZen
Figures of Cuezen Labs Private Limited, the primary company behind CueZen, for FY 2025. Revenue was ₹2.02 Cr. Net profit was ₹19.7 Lakh (10% margin). EBITDA was ₹29.7 Lakh (15% margin).
- ₹2.02 CrRevenue · FY 2025
- ₹19.7 LakhNet profit · 10% margin
- ₹29.7 LakhEBITDA · 15% margin
- ₹1 LakhPaid-up capital
Balance sheet, profit and loss, cash flow and ratios of Cuezen Labs Private Limited are on its company page.
Detailed financial statements for CueZen
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Timeline of CueZen
2 dated milestones of CueZen across 4 years, from founding to its latest funding, stage changes and deals.
- Founded CueZen is founded.
- Funding First funding round of $5.2M.
Competitors of CueZen
CueZen operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Omega Therapeutics, BiomeSense, BAMF Health, InpharmD and Shengshi Technology, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| omegatherapeutics.com | 2016 | Cambridge, United States | $211M | 93 | Platform for human genome study is provided for precision medicine. | |
| biomesense.com | 2018 | Chicago, United States | $8.43M | 9 | AI-enabled platform for microbiome data generation and analysis is developed. | |
| bamfhealth.com | 2018 | Grand Rapids, United States | $4M | 25 | AI-enabled molecular imaging and theranostics for disease diagnostics are developed. | |
| inpharmd.com | 2014 | Atlanta, United States | $6.63M | – | Evidence-based drug information is provided to healthcare providers online. | |
| 4dmedvision.com | 2017 | Hangzhou, China | – | – | AI and cloud-based precision diagnosis tools for healthcare are developed. | |
| lifeomic.com | 2016 | Indianapolis, United States | – | 111 | Storage, management and analysis of omic data for health applications | |
| datma.com | 2016 | Beaverton, United States | $2.5M | – | Provider of software to clinics for decision-making and omics data automation | |
| umethod.com | 2012 | Raleigh, United States | – | – | Precision medicine software is provided for chronic disease treatment. | |
| dhctech.com | 2016 | Haidian, China | – | – | AI-based chronic disease management tool |
Detailed competitors of CueZen
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of CueZen
The website of CueZen (cuezen.com) receives about 1.4K visits a month.
- Monthly visits1.4K
▲ 16.5% vs previous month
Latest news on Cuezen
Complete news archive for CueZen
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Similar companies to CueZen
10 companies that operate in the same segment as CueZen (Clinical IT & Data Platforms), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Provider of fitness memberships encompassing group classes, gyms, and at-home workouts | 2016 | Bengaluru, Karnataka, India | USD 713.57 M | – | – | |
Employee health benefits are facilitated via a cloud-based platform. | 2007 | Plymouth Meeting, Pennsylvania, United States | USD 228.3 M | – | – | |
Healthcare appointments are booked online via Zocdoc's platform. | 2007 | New York, New York, United States | USD 425.97 M | USD 4.66 M | 233 | |
Virtual physical therapy and digital pain care solutions are provided. | 2015 | San Francisco, California, United States | USD 854.44 M | – | – | |
Tech-enabled mental health solutions for employers are provided. | 2016 | New York, New York, United States | USD 508.73 M | – | – | |
App-based health insurance is offered to individuals and businesses. | 2016 | Paris, France | USD 863.12 M | – | – | |
Virtual care programs for managing chronic diseases are provided. | 2011 | San Francisco, California, United States | USD 450.12 M | USD 260.21 M | – | |
AI-driven EMR and practice management software is delivered for clinics. | 2010 | Boca Raton, Florida, United States | USD 329.17 M | – | – | |
Cloud-based administrative tools for healthcare providers are offered. | 1997 | Watertown, United States | USD 40 M | – | – | |
Membership-based primary care platform is offered for employees and consumers. | 2007 | San Francisco, California, United States | USD 402.56 M | – | – |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about CueZen
CueZen was founded in 2021 and raised its 1st funding round 4 years after it was founded.
CueZen is headquartered in Seattle, United States. It is registered at Seattle, Washington, United States.
Ankur Teredesai is the current CEO of CueZen. They have also founded this company.
CueZen is a funded company, having raised a total of $5.2M across 1 funding round to date. The company's 1st funding round was a Seed of $5.2M, raised on Apr 2025.
The primary company behind CueZen, Cuezen Labs Private Limited, reported revenue of ₹2.02 Cr for FY 2025.
Provider of AI powered personalization engine for health behavior change. The engine facilitates the creation of personalized health coaching agents, enabling seamless auto updates for digital twins and maintaining data security within the clients cloud. The platform integrates with various health trackers and leverages existing AI and health investments. It is designed for scalability and supports government grade security and compliance standards. The solution aims to enhance health outcomes through hyper personalized nudges, enhancing enrollment, engagement, and adherence to health programs. It offers end to end capabilities for enterprises seeking to enhance personalized health engagement.
CueZen's top competitors include Omega Therapeutics, BAMF Health and dātma.
CueZen offers Personalization Engine and Health Coaching Platform.
CueZen has 3 investors. Key investors include Point72 Ventures, Pack Ventures, and Fortson Venture Capital.
CueZen operates through Cuezen Labs Private Limited.
The legal entities of CueZen currently have 2 directors, including Ranjith Parakkunnath, Sharath Chandra Mysore Ganesh.